Quick Answer
Jade Biosciences, Inc. reported Total Assets of $349.78 million for fiscal year 2025.
Jade Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $349.78M | +380.5% |
| 2024 | $72.80M | -42.9% |
| 2023 | $127.42M | -5.8% |
| 2022 | $135.30M | -22.8% |
| 2021 | $175.36M | +3619.3% |
| 2020 | $4.71M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $202.45M | +122.6% | -9.6% |
| June 30, 2025 | $223.97M | +100.5% | +188.9% |
| March 31, 2025 | $77.53M | -27.4% | +6.5% |
| December 31, 2024 | $72.80M | -42.9% | -20.0% |
| September 30, 2024 | $90.96M | -35.4% | -18.6% |
| June 30, 2024 | $111.69M | -28.3% | +4.6% |
| March 31, 2024 | $106.82M | -14.1% | -16.2% |
| December 31, 2023 | $127.42M | -5.8% | -9.6% |
- Jade Biosciences, Inc. showed an increase of +380.5% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Jade Biosciences, Inc.’s total assets has grown by 7318.5% (from $4.71 million to $349.78 million).
- The most recent figure is from Jade Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: